NIH-funded research NIH-funded research

Understanding Osteoporosis through Body Chemistry

Official title: Comprehensive Metabolomics Study of Osteoporosis

Funded at Tulane University of Louisiana · NIH-11118855 · Data updated 2026-11-12

This project aims to find new ways to predict, diagnose, and treat osteoporosis by looking closely at the chemical makeup of our bodies, especially in older adults and different ethnic groups.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionTulane University of Louisiana
NIH-funded
Lab location1 site (New Orleans, United States)
Project startSeptember 15, 2017
Project endJune 30, 2027
Funding year2025
Award (this year)$472,141
NIH project number5U19AG055373-09
Project IDNIH-11118855 on NIH RePORTER

Who could benefit from this research

Could help

Patients who are older adults, particularly those with or at risk for osteoporosis, and individuals from diverse ethnic backgrounds, especially African Americans, may be ideal candidates for future related studies.

Less likely to help

Patients whose condition is not related to osteoporosis or metabolic bone health may not directly benefit from this specific line of inquiry.

What this research studies

Osteoporosis is a common bone disease that makes bones weak and prone to fractures, and we currently lack good ways to understand and treat it. This project explores the body's chemical profiles, called metabolomics, to uncover new clues about why some people get osteoporosis and others don't. By studying these chemical patterns in diverse groups, including older adults and different ethnicities, we hope to find new markers that can help us better predict who is at risk and develop more effective treatments. We will also work to confirm the identity and role of these chemical markers in bone health.

Why it matters

Potential benefit: If successful, this work could lead to earlier detection, more accurate diagnoses, and new treatment options for osteoporosis, potentially reducing the risk of fractures.

How similar studies have gone: While metabolomics has shown promise in other disorders, comprehensive human metabolomics for osteoporosis, particularly addressing sex and ethnic differences, is still a relatively new and understudied area.

Where this research is happening

  • Tulane University of Louisiana
    New Orleans, United States
    Active

Researchers

  • Principal investigator: Zhao, Qi — Tulane University of Louisiana
  • Study coordinator: Zhao, Qi

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.